These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 27429750)

  • 1. Assessing the Impact of Psychotropic Medication Changes on Challenging Behavior of Individuals with Intellectual Disabilities.
    Valdovinos MG; Henninger-McMahon M; Schieber E; Beard L; Conley B; Haas A
    Int J Dev Disabil; 2016; 62(3):200-211. PubMed ID: 27429750
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adverse Side Effects of Psychotropic Medication and Challenging Behavior: Pilot Work Assessing Impact.
    Valdovinos MG; Schieber E; McMahon M; Beard L; Wilkinson A; Carpenter J
    J Dev Phys Disabil; 2017 Dec; 29(6):969-982. PubMed ID: 29398883
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of psychotropic medication use and association with challenging behaviour in adults with an intellectual disability. A total population study.
    Bowring DL; Totsika V; Hastings RP; Toogood S; McMahon M
    J Intellect Disabil Res; 2017 Jun; 61(6):604-617. PubMed ID: 28090687
    [TBL] [Abstract][Full Text] [Related]  

  • 4. De-Prescribing of Psychotropic Medications in the Adult Population with Intellectual Disabilities: A Commentary.
    Flood B
    Pharmacy (Basel); 2018 Mar; 6(2):. PubMed ID: 29601493
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Descriptive Longitudinal Analysis of Stereotypy and Corresponding Changes in Psychotropic Medication.
    Piersma D; Aguilar M; Seibert H; Boyle B; Griffith G; Valdovinos MG
    Dev Neurorehabil; 2022 Jul; 25(5):298-308. PubMed ID: 34865596
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Psychotropic medication use for challenging behaviors in persons with intellectual disabilities: an overview.
    Matson JL; Neal D
    Res Dev Disabil; 2009; 30(3):572-86. PubMed ID: 18845418
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Psychotropic prescribing for persons with intellectual disabilities and other psychiatric disorders.
    Edelsohn GA; Schuster JM; Castelnovo K; Terhorst L; Parthasarathy M
    Psychiatr Serv; 2014 Feb; 65(2):201-7. PubMed ID: 24233105
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Psychotropic medications use and side effects of individuals with intellectual and developmental disabilities.
    Charlot LR; Doerfler LA; McLaren JL
    J Intellect Disabil Res; 2020 Nov; 64(11):852-863. PubMed ID: 32959471
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Challenging behavior and related factors in people with intellectual disability living in residential care centers in Israel.
    Sinai A; Tenenbaum A; Aspler S; Lotan M; Morad M; Merrick J
    Front Public Health; 2013; 1():13. PubMed ID: 24350182
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors associated with use of medication for behavioral challenges in adults with intellectual and developmental disability.
    Erickson SR; Houseworth J; Esler A
    Res Dev Disabil; 2022 Apr; 123():104182. PubMed ID: 35131683
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characteristics and the trajectory of psychotropic medication use in general and antipsychotics in particular among adults with an intellectual disability who exhibit aggressive behaviour.
    Deb S; Unwin G; Deb T
    J Intellect Disabil Res; 2015 Jan; 59(1):11-25. PubMed ID: 24450426
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Intellectual disabitily, challenging behavior, and care: A systematic literature review].
    Weber N; Duville C; Loizeau V; Morvillers JM
    Rech Soins Infirm; 2019 Sep; 138(3):18-28. PubMed ID: 31959238
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term functional stability of problem behavior exposed to psychotropic medications.
    Cox AD; Virues-Ortega J
    J Appl Behav Anal; 2022 Feb; 55(1):214-229. PubMed ID: 34329500
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Appropriateness of psychotropic medication use in a cohort of adolescents with intellectual disability in Queensland, Australia.
    Song M; Ware RS; Doan TN; McPherson L; Trollor JN; Harley D
    BJPsych Open; 2020 Nov; 6(6):e142. PubMed ID: 33198847
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological interventions for challenging behaviour in children with intellectual disabilities: a systematic review and meta-analysis.
    McQuire C; Hassiotis A; Harrison B; Pilling S
    BMC Psychiatry; 2015 Nov; 15():303. PubMed ID: 26611280
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Psychotropic and Anticonvulsant Medication: Individuals With Intellectual and Developmental Disabilities Who Transitioned to the Community From an Institution.
    Kelly S; Su Y
    Intellect Dev Disabil; 2015 Aug; 53(4):289-300. PubMed ID: 26214558
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Psychotropic medication and psychotherapeutic treatment of adults with intellectual disabilities (PROMPT-ID): a cross-sectional, epidemiological study in Saxony, Germany.
    Koch A; Dobrindt J; Schützwohl M
    BMJ Open; 2018 Dec; 8(12):e025947. PubMed ID: 30573492
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mental illness, challenging behaviour, and psychotropic drug prescribing in people with intellectual disability: UK population based cohort study.
    Sheehan R; Hassiotis A; Walters K; Osborn D; Strydom A; Horsfall L
    BMJ; 2015 Sep; 351():h4326. PubMed ID: 26330451
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Psychotropic medication use in adolescents with intellectual disability living in the community.
    Doan T; Ware R; McPherson L; van Dooren K; Bain C; Carrington S; Einfeld S; Tonge B; Lennox N
    Pharmacoepidemiol Drug Saf; 2014 Jan; 23(1):69-76. PubMed ID: 23929635
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.